Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Optimized sequential purification protocol for in vivo site-specific biotinylated full-length dengue virus capsid protein.

Chong MK, Parthasarathy K, Yeo HY, Ng ML.

Protein Eng Des Sel. 2013 May;26(5):377-87. doi: 10.1093/protein/gzs107.

2.
3.

Optimization of Dengue-3 recombinant NS1 protein expression in E. coli and in vitro refolding for diagnostic applications.

Athmaram TN, Saraswat S, Misra P, Shrivastava S, Singh AK, Verma SK, Gopalan N, Behara PK, Rao PV.

Virus Genes. 2013 Apr;46(2):219-30. doi: 10.1007/s11262-012-0851-5.

PMID:
23188193
4.
5.

A recombinant capsid protein from Dengue-2 induces protection in mice against homologous virus.

Lazo L, Hermida L, Zulueta A, Sánchez J, López C, Silva R, Guillén G, Guzmán MG.

Vaccine. 2007 Jan 22;25(6):1064-70.

PMID:
17097199
6.
7.

Expression, purification and characterization of in vivo biotinylated dengue virus envelope domain III based tetravalent antigen.

Batra G, Talha SM, Nemani SK, Dhar N, Swaminathan S, Khanna N.

Protein Expr Purif. 2010 Nov;74(1):99-105. doi: 10.1016/j.pep.2010.04.017.

PMID:
20435144
8.

In vitro assembly of nucleocapsid-like particles from purified recombinant capsid protein of dengue-2 virus.

López C, Gil L, Lazo L, Menéndez I, Marcos E, Sánchez J, Valdés I, Falcón V, de la Rosa MC, Márquez G, Guillén G, Hermida L.

Arch Virol. 2009;154(4):695-8. doi: 10.1007/s00705-009-0350-8.

PMID:
19305942
10.

High yield production of pigeon circovirus capsid protein in the E. coli by evaluating the key parameters needed for protein expression.

Lai GH, Lin YC, Tsai YL, Lien YY, Lin MK, Chen HJ, Chang WT, Tzen JT, Lee MS.

BMC Vet Res. 2014 May 22;10:115. doi: 10.1186/1746-6148-10-115.

11.

Characterization of soluble RNA-dependent RNA polymerase from dengue virus serotype 2: The polyhistidine tag compromises the polymerase activity.

Kamkaew M, Chimnaronk S.

Protein Expr Purif. 2015 Aug;112:43-9. doi: 10.1016/j.pep.2015.04.008.

PMID:
25921066
13.

Recombinant production of the amino terminal cytoplasmic region of dengue virus non-structural protein 4A for structural studies.

Hung YF, Valdau O, Schünke S, Stern O, Koenig BW, Willbold D, Hoffmann S.

PLoS One. 2014 Jan 23;9(1):e86482. doi: 10.1371/journal.pone.0086482.

14.

Rapid purification of recombinant dengue and West Nile virus envelope Domain III proteins by metal affinity membrane chromatography.

Tan LC, Chua AJ, Goh LS, Pua SM, Cheong YK, Ng ML.

Protein Expr Purif. 2010 Nov;74(1):129-37. doi: 10.1016/j.pep.2010.06.015.

PMID:
20600950
15.

Bacterial expression and purification of hepatitis C virus capsid proteins of different size.

Handschuh G, Caselmann WH.

J Hepatol. 1995 Feb;22(2):143-50.

PMID:
7790702
16.

A plasmid expression system for quantitative in vivo biotinylation of thioredoxin fusion proteins in Escherichia coli.

Smith PA, Tripp BC, DiBlasio-Smith EA, Lu Z, LaVallie ER, McCoy JM.

Nucleic Acids Res. 1998 Mar 15;26(6):1414-20.

17.

Efficient production of an engineered apoptin from chicken anemia virus in a recombinant E. coli for tumor therapeutic applications.

Lee MS, Sun FC, Huang CH, Lien YY, Feng SH, Lai GH, Lee MS, Chao J, Chen HJ, Tzen JT, Cheng HY.

BMC Biotechnol. 2012 Jun 6;12:27. doi: 10.1186/1472-6750-12-27.

18.

Bacterially expressed and refolded envelope protein (domain III) of dengue virus type-4 binds heparan sulfate.

Pattnaik P, Babu JP, Verma SK, Tak V, Rao PV.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Feb 1;846(1-2):184-94.

PMID:
17011249
19.

Purification of a rat neurotensin receptor expressed in Escherichia coli.

Tucker J, Grisshammer R.

Biochem J. 1996 Aug 1;317 ( Pt 3):891-9.

20.

In vivo biotinylation of bacterial magnetic particles by a truncated form of Escherichia coli biotin ligase and biotin acceptor peptide.

Maeda Y, Yoshino T, Matsunaga T.

Appl Environ Microbiol. 2010 Sep;76(17):5785-90. doi: 10.1128/AEM.00916-10.

Items per page

Supplemental Content

Support Center